Cargando…

Redefying the therapeutic strategies against cardiorenal morbidity and mortality: Patient phenotypes

Chronic kidney disease (CKD) patients face an unacceptably high morbidity and mortality, mainly from cardiovascular diseases. Diabetes mellitus, arterial hypertension and dyslipidemia are highly prevalent in CKD patients. Established therapeutic protocols for the treatment of diabetes mellitus, arte...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bacharaki, Dimitra, Petrakis, Ioannis, Stylianou, Kostas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2023
Materias:	Opinion Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074996/ https://www.ncbi.nlm.nih.gov/pubmed/37033683 http://dx.doi.org/10.4330/wjc.v15.i3.76

Ejemplares similares

Emperor’s syndrome in the COVID-19 era: Time for patient-centered nephrology?
por: Bacharaki, Dimitra, et al.
Publicado: (2021)

Cardiorenal Syndrome: Challenges in Everyday Clinical Practice and Key Points towards a Better Management
por: Georgopoulou, Theodora, et al.
Publicado: (2023)

Adherence to the Mediterranean Diet Is Associated with a More Favorable Left Ventricular Geometry in Patients with End-Stage Kidney Disease
por: Bacharaki, Dimitra, et al.
Publicado: (2022)

Therapeutic Options for the Management of the Cardiorenal Syndrome
por: Koniari, Katerina, et al.
Publicado: (2010)

Case Report of Cardiorenal Syndrome with Ascites and Listeria monocytogenes Peritonitis: The Role of Large-Volume Paracentesis and Albumin Replacement
por: Karagiannis, Minas, et al.
Publicado: (2022)

The Pathophysiological Role of Heat Shock Response in Autoimmunity: A Literature Review
por: Androvitsanea, Ariadni, et al.
Publicado: (2021)

Oxidants and Cardiorenal Vascular Remodeling—Insights from Rare Genetic Tubulopathies: Bartter’s and Gitelman’s Syndromes
por: Sgarabotto, Luca, et al.
Publicado: (2023)

Effects of Finerenone on Cardiovascular and Chronic Kidney Diseases: A New Weapon against Cardiorenal Morbidity and Mortality—A Comprehensive Review
por: Piccirillo, Francesco, et al.
Publicado: (2023)

Dent-2 disease with a Bartter-like phenotype caused by the Asp631Glu mutation in the OCRL gene
por: Drosataki, Eleni, et al.
Publicado: (2022)

Two cases of glomerular involvement after vaccination against COVID-19: epiphenomenon or causality?
por: Psyllaki, Anna, et al.
Publicado: (2021)

Insights Into the Results of Sotagliflozin Cardiovascular Outcome Trials: Is Dual Inhibition the Cherry on the Cake of Cardiorenal Protection?
por: Koufakis, Theocharis, et al.
Publicado: (2021)

Glucocorticoid Receptor Signaling in NSCLC: Mechanistic Aspects and Therapeutic Perspectives
por: Papavassiliou, Kostas A., et al.
Publicado: (2023)

Morbidity Associated with Chronic Hyponatremia
por: Decaux, Guy
Publicado: (2023)

Acute Childhood Cardiorenal Syndrome and Impact of Cardiovascular Morbidity on Survival
por: Olowu, Wasiu A.
Publicado: (2011)

Vpu Matchmakers as a Therapeutic Strategy for HIV Infection
por: Montal, Mauricio
Publicado: (2009)

Cardiorenal syndrome
por: Schetz, Miet
Publicado: (2009)

The p.Pro482Ala Variant in the CNNM2 Gene Causes Severe Hypomagnesemia Amenable to Treatment with Spironolactone
por: Petrakis, Ioannis, et al.
Publicado: (2022)

Biomarkers in Cardiorenal Syndrome
por: Goffredo, Giovanni, et al.
Publicado: (2021)

The Diabetic Cardiorenal Nexus
por: D’Elia, John A., et al.
Publicado: (2022)

Targeting the metabolism of leukemia stem cells as a novel therapeutic strategy
por: Ho, Emmanuel A, et al.
Publicado: (2013)

Routine data for malaria morbidity estimation in Africa: challenges and prospects
por: Alegana, Victor A., et al.
Publicado: (2020)

Pumping iron: a potential target for novel therapeutics against schistosomes
por: Glanfield, Amber, et al.
Publicado: (2007)

Can Activation of NRF2 Be a Strategy against COVID-19?
por: Cuadrado, Antonio, et al.
Publicado: (2020)

Cardiorenal Syndromes and Sepsis
por: Chelazzi, C., et al.
Publicado: (2011)

Biomarkers in Cardiorenal Syndromes
por: Fu, Shihui, et al.
Publicado: (2018)

Range of adiposity and cardiorenal syndrome
por: Pazos, Fernando
Publicado: (2020)

Cardiorenal Interactions: A Review
por: Verma, Sanam, et al.
Publicado: (2022)

The Switch between Protective and Nonprotective Autophagy; Implications for Autophagy Inhibition as a Therapeutic Strategy in Cancer
por: Gewirtz, David A.
Publicado: (2020)

What if HIV were unable to develop resistance against a new therapeutic agent?
por: Wainberg, Mark A, et al.
Publicado: (2013)

Gene Editing Approaches against Viral Infections and Strategy to Prevent Occurrence of Viral Escape
por: White, Martyn K., et al.
Publicado: (2016)

Investigating the Value of Abatacept in the Treatment of Rheumatoid Arthritis: A Systematic Review of Cost-Effectiveness Studies
por: Athanasakis, Kostas, et al.
Publicado: (2013)

CX3CL1 Worsens Cardiorenal Dysfunction and Serves as a Therapeutic Target of Canagliflozin for Cardiorenal Syndrome
por: Zheng, Cankun, et al.
Publicado: (2022)

Social Distancing and Lessons from Sweden's Lenient Strategy against Corona Virus Disease 2019
por: Yoo, Jin-Hong
Publicado: (2020)

Cardiorenal Disease in COVID-19 Patients
por: Sifaat, Muhtasham, et al.
Publicado: (2022)

The Cardiorenal Syndrome: Making the Connection
por: Viswanathan, Gautham, et al.
Publicado: (2010)

The Cardiorenal Syndrome: A Review
por: Shah, B. N., et al.
Publicado: (2010)

Pharmacological Management of Cardiorenal Syndromes
por: House, Andrew A., et al.
Publicado: (2011)

Effects of Statins on Cardiorenal Syndrome
por: Yagi, Shusuke, et al.
Publicado: (2012)

Cardiorenal Syndromes: Pathophysiology to Prevention
por: McCullough, Peter A.
Publicado: (2010)

Cardiorenal Safety of OTC Analgesics
por: White, William B., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vc0n1hvk35eud1d26co76bslah